(PharmaNewsWire.Com, July 06, 2017 ) Browse 265 market data tables and 37 figures spread through 292 pages and in-depth TOC on “Womens Health Diagnostics Market by application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021” <||>rnhttp://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html Early buyers will receive 10% customization on reports.
The global women health diagnostics market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented nine segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end users, the women health diagnostics market is segmented into hospital & clinics, home healthcare, and diagnostic & imaging centers.
In 2015, the breast cancer segment accounted for the largest share of the women health diagnostics market. The large share of the breast cancer segment is attributed to the high prevalence of breast cancer across the world, increasing number of women opting for routine breast check-up, and rising awareness about advanced breast cancer diagnostic techniques.
The end user segment in this market is divided into hospitals & clinics, imaging & diagnostic centers and home care. In 2015, the hospitals and clinics segment accounted for the largest share of the global women’s health diagnostics market. The large share of this segment can be attributed to the fact that a greater proportion of patients (women) go to hospitals for the diagnosis/treatment of their health issues.
In 2015, North America accounted for the largest regional market, followed by Europe, Asia-Pacific, and the RoW. Asia-Pacific represents the fastest-growing region for the women health diagnostics market, primarily due to significant expansion and modernization of healthcare infrastructure, increasing per-capita income, and increasing focus of international device manufacturers on strengthening their distribution networks in this region. Moreover, the growing population in countries like China and India, epidemiological shift from infectious diseases to chronic diseases in this region are driving the growth of the women’s health diagnostics market in APAC.
Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
